These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22842882)

  • 1. [Blood - surely but safely!].
    Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):905-6. PubMed ID: 22842882
    [No Abstract]   [Full Text] [Related]  

  • 2. [XMRV is not pathogenic in human and has no significance for the safety of blood and blood products].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):1057-60. PubMed ID: 22842897
    [No Abstract]   [Full Text] [Related]  

  • 3. [Can virus safety of blood products be assured?].
    Krusius T
    Duodecim; 1994; 110(13):1227-30. PubMed ID: 7497931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogen Reduction: The State of the Science in 2019.
    Gehrie EA; Rutter SJ; Snyder EL
    Hematol Oncol Clin North Am; 2019 Oct; 33(5):749-766. PubMed ID: 31466602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood donor hemovigilance: impact for donor and recipient safety].
    Hauser L; Beyloune A; Simonet M; Bierling P
    Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the risk of an emerging pathogen entering the Canadian blood supply.
    Kleinman S; Cameron C; Custer B; Busch M; Katz L; Kralj B; Matheson I; Murphy K; Preiksaitis J; Devine D
    Transfusion; 2010 Dec; 50(12):2592-606. PubMed ID: 20553433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Orthopoxviruses: infections in humans. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):957-72. PubMed ID: 20853093
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood transfusion safety].
    Koistinen J
    Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunobiology--the neglected side of transfusion].
    Flesland O; Solheim BG
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2493. PubMed ID: 11070981
    [No Abstract]   [Full Text] [Related]  

  • 11. Neonatal transfusions.
    New HV; Stanworth SJ; Engelfriet CP; Reesink HW; McQuilten ZK; Savoia HF; Wood EM; Olyntho S; Trigo F; Wendel S; Lin Y; Hume H; Petäjä J; Krusius T; Villa S; Ghirardello S; von Lindern J; Brand A; Hendrickson JE; Josephson CD; Strauss RG; Luban NL; Paul W
    Vox Sang; 2009 Jan; 96(1):62-85. PubMed ID: 19121200
    [No Abstract]   [Full Text] [Related]  

  • 12. [Eliminating alanine aminotransferase (ALT) determination in screening of blood components for transfusion and plasma for fractionation. At the 52nd Meeting of the Blood Professional Circle 1 October 2003 the following vote (V30) was delivered].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jan; 47(1):82. PubMed ID: 15205830
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug use in blood donors].
    Berg JA; Schjøtt J
    Tidsskr Nor Laegeforen; 2016 May; 136(8):718-20. PubMed ID: 27143462
    [No Abstract]   [Full Text] [Related]  

  • 14. The Impact of Emerging Infectious Diseases on Chinese Blood Safety.
    He M; Wang J; Chen L; Liu J; Zeng P
    Transfus Med Rev; 2017 Apr; 31(2):94-101. PubMed ID: 27923518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal exposure transfusion concept.
    Menitove JE
    J Clin Apher; 1991; 6(4):194-5. PubMed ID: 1816237
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parvovirus B19. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):944-56. PubMed ID: 20853092
    [No Abstract]   [Full Text] [Related]  

  • 17. [Safety of blood transfusions; need for 'hemo-vigilance'].
    van Aken WG; van Rood JJ
    Ned Tijdschr Geneeskd; 1998 Feb; 142(6):281-4. PubMed ID: 9562726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period.
    Balint B; Vucetic D; Todorovic-Balint M; Borovcanin N; Jovanovic-Cupic S; Mandusic V
    Transfus Apher Sci; 2013 Aug; 49(1):103-4. PubMed ID: 23820432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Safety of blood and blood products in the face of recent reports on the transmissibility of Alzheimer's disease in an animal experiment].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):584. PubMed ID: 23529604
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quality assurance management system for therapy with blood and blood products].
    Diekamp U
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):664-5. PubMed ID: 9825053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.